Table 2.
Depression of miR-889-3p is associated with LNM and clinicopathological stage
| Characteristics | Patients (n = 61) |
MiR-889-3p expression |
P | χ2 | |
|---|---|---|---|---|---|
| Low (n = 30) | High (n = 31) | ||||
| Gender | 0.300 | 1.428 | |||
| Male | 36 | 20 | 16 | ||
| Female | 25 | 10 | 15 | ||
| Age(year) | 0.126 | 2.755 | |||
| 60 or less | 33 | 13 | 20 | ||
| >60 | 28 | 17 | 11 | ||
| Differentiation | 0.114 | 2.877 | |||
| Moderate and good | 39 | 16 | 23 | ||
| Poor | 22 | 14 | 8 | ||
| LNM | 0.020* | 6.003 | |||
| Negative | 36 | 13 | 23 | ||
| Positive | 25 | 17 | 8 | ||
| Tumor size | 0.300 | 1.326 | |||
| <3 cm | 37 | 16 | 21 | ||
| >3 cm | 24 | 14 | 10 | ||
| TNM stage | 0.010* | 7.096 | |||
| I/II | 35 | 22 | 13 | ||
| III | 26 | 7 | 18 | ||
*Indicated statistical significance (P < 0.05)